Bionano Genomics Announces Publication of Study from Sorbonne Université Showing that WGS Identified only 63% of Structural Variations that OGM Detected in Liver Cancer

October 4, 2022

https://www.globenewswire.com/news-release/2022/10/04/2527717/0/en/Bionano-Genomics-Announces-Publication-of-Study-from-Sorbonne-Universit%C3%A9-Showing-that-WGS-Identified-only-63-of-Structural-Variations-that-OGM-Detected-in-Liver-Cancer.html

SAN DIEGO, Oct. 04, 2022 (GLOBE NEWSWIRE) — Bionano Genomics, Inc. (Nasdaq:BNGO) today announced the publication of a study showing the use of optical genome mapping (OGM) to investigate a molecular subgroup of hepatocellular carcinoma (HCC), which is the most common form of liver cancer, in order to explore the complex structural variations (SVs) induced by replication stress. In this study, OGM helped unravel replication stress-induced events, which may cause or contribute to genomic instability in cancer cells, potentially leading to the activation of oncogenes and disruption of tumor suppressors.

Read more at globenewswire.com

Related news for (BNGO)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.